This Wiley Dedifferentiated Liposarcoma (DDL) Knowledge Hub publishes the latest clinically relevant content from trusted sources on the latest advancements in research and treatment policies/guidelines in the field of DDL.
The aim of the Knowledge Hub is to educate relevant healthcare professionals on the latest research and provide them with the tools to easily apply the latest recommendations to make meaningful interventions in best-patient care.
All content published on the resource is reviewed by an independent expert editorial panel proposed by the American Cancer Society Journals, and presented in an accessible format for easy application in everyday clinical practice. The editorial panel worked in coordination with Wiley on the content curation for the creation of this knowledge hub. The American Cancer Society cannot be held responsible for errors or any consequences arising from the use of information contained in this resource.
This Knowledge Hub is supported by an educational grant from Boehringer Ingelheim. The supporters have had no influence in the selection of the Editorial Panel or the creation of content.